inflammatory bowel disease

(redirected from Inflammatory bowel)
Also found in: Dictionary, Thesaurus, Encyclopedia.

inflammatory bowel disease

 
any of various inflammatory diseases of the bowel whose etiology is unknown, including crohn's disease and ulcerative colitis.

inflammatory bowel disease (IBD),

general term for Crohn disease and ulcerative colitis, chronic disorders of the small and large intestine, of unknown cause, with conspicuous inflammatory features and distinctive but overlapping signs and symptoms.

inflammatory bowel disease

n. Abbr. IBD
Any of several chronic disorders of the gastrointestinal tract, especially Crohn's disease and ulcerative colitis, characterized by inflammation and ulceration of the intestine and resulting in abdominal cramping and diarrhea.

inflammatory bowel disease

inflammatory bowel disease

A general term for the symptoms associated with specific types of inflammation of the large intestine, including Crohn's disease–CD, ulcerative colitis–UC as well as idiopathic inflammatory bowel disease, a diagnosis of exclusion that clinically and pathologically mimics and/or overlaps CD and UC Heredity First-degree relatives of Pts with CD and UC have an 8- to 10-fold ↑ risk of developing the same form of colitis DiffDx Ischemia, radiation, uremia, cytotoxic drugs, heavy metal intoxication; IBD Pts often have ≥ 2 of following: Visible abdominal distension, relief of pain upon defecation, looser and more frequent bowel movements when the pain occurs; ♂:♀ ratio, 2:1; more common in Jews; IBD is associated with mucocutaneous disease–pyoderma gangrenosa, erythema nodosum, oral ulcers, annular erythema, vascular thromboses, epidermolysis bullosa, ocular disease–uveitis, iridocyclitis, hepatopathy–CAH, cirrhosis, sclerosing cholangitis, arthropathy–ankylosing spondylitis. Cf Irritable bowel syndrome Treatment Corticosteroids—or corticotropin–favored by some clinicians, aminosalicylates–sulfasalazine and 5-aminosalicylic acid, immunomodulatory agents–azathioprine, mercaptopurine, cyclosporine, MTX, metronidazole, antibiotics and nutritional support–both more effective in Crohn's disease, resulting in ↓ Sx, ↓ inflammatory sequelae, improved nutritional status.
Inflammatory bowel disease  
Clinical  Ulcerative colitis Crohn's disease
Rectal bleeding  Common  Rare
Abdominal mass  Rare  10-15%
Abdominal pain  Left-sided  Right-sided
Abnormal endoscopy  95%  < 50%
Perforation  12%  4%
Colon carcinoma  5-10%  Rare
Response to steroids  75%  25%
Surgical outcome Excellent  Fair
Rectal involvement  > 95%  !0%
Radiology
Ileal involvement  Rare  Usual
Cross-hatched ulcers  Rare  Occasional
Thumbprinting  Absent  Common
Fissuring  Absent  Common
Skip areas  Absent  Common
Strictures  Absent  Common
Pathology
Distribution  Diffuse  Focal
   Superficial  Transmural
Mucosal atrophy Regeneration  Marked Minimal
Hyperemia  Often marked  Minimal
Crypt abscess  Common  Rare
Cytoplasmic mucin  Decreased  Intact
Lymphoid aggregates  Rare  Common
Lymph nodes  Reactive hyperplasia  -----
Edema  Minimal Marked
Granulomas  Absent  60%  

in·flam·ma·to·ry bow·el dis·ease

(IBD) (in-flam'ă-tōr-ē bow'ĕl di-zēz')
General term for Crohn disease and ulcerative colitis, chronic disorders of the small and large intestine, autoimmune, with conspicuous inflammatory features and distinctive but overlapping signs and symptoms.

Inflammatory bowel disease (IBD)

Ulcerative colitis or Crohn's colitis; chronic conditions characterized by periods of diarrhea, bloating, abdominal cramps, and pain, sometimes accompanied by weight loss and malnutrition because of the inability to absorb nutrients.

inflammatory

pertaining to or emanating from inflammation.

inflammatory bowel disease
an idiopathic disease of cats, principally, and dogs characterized by cyclic bouts of vomiting and or diarrhea which may continue over periods of years; see also lymphocytic-plasmacytic enteritis.
inflammatory edema
a disease of the subcutis caused usually by Clostridium spp.
inflammatory response
References in periodicals archive ?
Furthermore, they say, the precise role of Th1-Th2 balance in inflammatory bowel disease remains unresolved, as does the seeming contradiction between their research and the hygiene hypothesis' assumption that Th2 responses usually overpower Th1 responses.
Avaxia's lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease.
The successful preclinical proof of concept for SC12267 for treating chronic inflammatory bowel diseases is very important to us," commented Ulrich Dauer, CEO, 4SC AG.
Devise corrective measures for pipeline projects by understanding Inflammatory Bowel Disease pipeline depth and focus of Inflammatory Bowel Disease therapeutics.
About SGM-1019 SGM-1019 is an orally delivered small molecule initially being developed by Second Genome for the treatment of Crohn's disease, an indication in inflammatory bowel disease.
2013* 45 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Alvine Pharmaceuticals, Inc.
Inflammatory Bowel Disease - Pipeline Review, H2 2011', provides an overview of the Inflammatory Bowel Disease therapeutic pipeline.
Therapies and Biomarkers for Inflammatory Bowel Disease
com) announces updates to their Inflammatory Bowel research database.
a privately-held biotech company using its proprietary platform technology to develop orally-active antibody therapeutics for the treatment of gastrointestinal diseases, is proud to announce that it has received a second round of funding from the National Institutes of Health for its work in inflammatory bowel disease.
Inflammatory Bowel Disease - Pipeline Review, Q2 2011', provides an overview of the Inflammatory Bowel Disease therapeutic pipeline.

Full browser ?